Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

The outbreak of COVID-19 has drawn great attention around the world. SARS-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation period. In particular, the emergence of asymptomatic infections has made the epidemic even more severe. Therefore, early diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ya-Nan, Jiang, Dingding, Wang, Xuejun, Liu, Yunqi, Wei, Dacheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266891/
https://www.ncbi.nlm.nih.gov/pubmed/37362324
http://dx.doi.org/10.1016/j.cclet.2023.108688
_version_ 1785058828975341568
author Tang, Ya-Nan
Jiang, Dingding
Wang, Xuejun
Liu, Yunqi
Wei, Dacheng
author_facet Tang, Ya-Nan
Jiang, Dingding
Wang, Xuejun
Liu, Yunqi
Wei, Dacheng
author_sort Tang, Ya-Nan
collection PubMed
description The outbreak of COVID-19 has drawn great attention around the world. SARS-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation period. In particular, the emergence of asymptomatic infections has made the epidemic even more severe. Therefore, early diagnosis and timely management of suspected cases are essential measures to control the spread of the virus. Developing simple, portable, and accurate diagnostic techniques for SARS-CoV-2 is the key to epidemic prevention. The advantages of point-of-care testing technology make it play an increasingly important role in viral detection and screening. This review summarizes the point-of-care testing platforms developed by nucleic acid detection, immunological detection, and nanomaterial-based biosensors detection. Furthermore, this paper provides a prospect for designing future highly accurate, cheap, and convenient SARS-CoV-2 diagnostic technology.
format Online
Article
Text
id pubmed-10266891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
record_format MEDLINE/PubMed
spelling pubmed-102668912023-06-15 Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms Tang, Ya-Nan Jiang, Dingding Wang, Xuejun Liu, Yunqi Wei, Dacheng Chin Chem Lett Article The outbreak of COVID-19 has drawn great attention around the world. SARS-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation period. In particular, the emergence of asymptomatic infections has made the epidemic even more severe. Therefore, early diagnosis and timely management of suspected cases are essential measures to control the spread of the virus. Developing simple, portable, and accurate diagnostic techniques for SARS-CoV-2 is the key to epidemic prevention. The advantages of point-of-care testing technology make it play an increasingly important role in viral detection and screening. This review summarizes the point-of-care testing platforms developed by nucleic acid detection, immunological detection, and nanomaterial-based biosensors detection. Furthermore, this paper provides a prospect for designing future highly accurate, cheap, and convenient SARS-CoV-2 diagnostic technology. Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. 2023-06-15 /pmc/articles/PMC10266891/ /pubmed/37362324 http://dx.doi.org/10.1016/j.cclet.2023.108688 Text en © 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tang, Ya-Nan
Jiang, Dingding
Wang, Xuejun
Liu, Yunqi
Wei, Dacheng
Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title_full Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title_fullStr Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title_full_unstemmed Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title_short Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
title_sort recent progress on rapid diagnosis of covid-19 by point-of-care testing platforms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266891/
https://www.ncbi.nlm.nih.gov/pubmed/37362324
http://dx.doi.org/10.1016/j.cclet.2023.108688
work_keys_str_mv AT tangyanan recentprogressonrapiddiagnosisofcovid19bypointofcaretestingplatforms
AT jiangdingding recentprogressonrapiddiagnosisofcovid19bypointofcaretestingplatforms
AT wangxuejun recentprogressonrapiddiagnosisofcovid19bypointofcaretestingplatforms
AT liuyunqi recentprogressonrapiddiagnosisofcovid19bypointofcaretestingplatforms
AT weidacheng recentprogressonrapiddiagnosisofcovid19bypointofcaretestingplatforms

Ejemplares similares